Metro Weekly

HIV-vaccine trial halted after review board finds no effect

“These results do not change the fundamental view that an AIDS vaccine remains critical to any long-term strategy to end the AIDS epidemic.”

Matthew Rose, a D.C. participant in the HVTN 505 HIV-vaccine trial, which was halted today. The trial was called off after an independent review board found the vaccine neither prevented HIV infections nor reduced the amount of HIV in people infected with virus. The trial focused specifically on gay and bisexual men, and men who otherwise have sex with men, and transgender people. (Reuters

Follow Will O'Bryan on Twitter @wobryan.